Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2017

Feb 13, 2018

SELL
$168.79 - $188.59 $5.06 Million - $5.66 Million
-30,000 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $5.02 Million - $5.73 Million
30,000
30,000 $5.59 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Avalon Global Asset Management LLC Portfolio

Follow Avalon Global Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avalon Global Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avalon Global Asset Management LLC with notifications on news.